- You must enroll in this course to access course content.
- IFS 2021 access closed!
IFS 2021 is now closed
Need an extension?
This is an on-demand course, there are only distance CEUs
Acupuncture | NCCAOM | California Category 1 | ABORM | Florida | Texas | CTCMA | TCM Fachverband Schweiz |
CEU/PDA/CAE | 2 PDA AOM-BIO | 2 CEU | 2 CEU | 2 CEU BIOMED | 2 CAE BIOMED | 2 CEU B3 | 2 CEU GEN |
Naturopath | BCNA Category C | CONO | OBNM | CNDA | WANP Category 2 |
Credits | 2 CE | 2 CE GENERAL | 2 CE GENERAL | 2 CE GENERAL | 2 CE GENERAL |
Description:
The oocyte is most influenced by a woman’s maternal grandmother’s health and wellbeing than any other variable in her lifetime – known as the trigenerational effect.
In a clinical context when we are presented with a woman diagnosed with oocyte aging or premature ovarian insufficiency (POI) we are given a clinical conundrum that challenges our belief in current literature, ethical framework of practice and an awareness that some patients recover from oopause to resume cycling normally. How is this so and how can we optimise this for all women?
There are key strategies we can incorporate that implement an understanding of oocyte biology and mitochondrial efficiency that can swing a woman’s fertility back into optimal cycling and oocyte health. Fertility care is inundated with women who face these diagnostic limitations and yearn for offspring from their own gametes. By understanding the requirements, considering new research and clinical expertise we can improve these statistics significantly and support women in achieving this goal.
Learning Objectives:
- Participants will understand the role of genetics and epigenetic drivers in reproductive competence and oocyte health
- Participants will understand role of mitochondrial health in improving oocyte maturation and receptivity to fertility and appropriate treatment strategies to achieve these goals
- Participants will acquire strategic and optimal treatment strategies to effectively support their patients’ health and improve reproductive competence, fertility outcomes and oocyte viability